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Lead (Pb) and polychlorinated biphenyls 
(PCBs) are widespread environmental con-
taminants known for their developmental 
neurotoxicity. Despite differences in their 
chemical structures and properties, early expo-
sure to these pollutants appears to produce 
similar effects on neurobehavior, including 
impulsivity, hyperactivity, and impairment 
in executive function (Boucher et al. 2009a; 
Brockel and Cory-Slechta 1998; Nicolescu 
et al. 2010; Rice 1999). These effects have 
been hypothesized to reflect dysfunction of 
the prefrontal cortex (Levin et al. 1992; Meng 
et al. 2005) and alterations in dopamine func-
tion (Seegal et al. 1997; White et al. 2007).
The term “executive function” refers to 
a set of cognitive processes involved in goal-
directed behaviors, which are often elicited 
in new and/or complex situations (Norman 
and Shallice 1986). One key component of 
executive function is the ability to inhibit 
dominant or prepotent responses when 
necessary (Miyake et al. 2000), and impair-
ment in this ability can result in impulsivity. 
Studies investigating the relation of Pb and 
PCB exposure to impulsivity and executive 
function have relied exclusively on neuro-
psychological and observational assessments. 
Because of their high temporal resolution, 
event-related potentials (ERPs) make it pos-
sible to evaluate children’s performance in 
specific response components arrayed across 
time. ERPs recorded during a task requiring 
response inhibition could help in understand-
ing the neurobehavioral effects associated with 
Pb and PCB exposures in children.
The Inuit from Nunavik (Arctic Québec, 
Canada) are among the most heavily exposed 
populations on earth to PCBs and methyl-
mercury (MeHg) because of the long-range 
transport of these chemicals via atmospheric 
and ocean currents and their bioaccumulation 
in fish and sea mammals that are staples of the 
traditional Inuit diet (Muckle et al. 2001). Pb 
exposure is also a concern because of the use 
of Pb cartridges for game bird hunting despite 
governmental regulations designed to dis-
courage their use (Lévesque et al. 2003). This 
study was designed to examine the relation 
of exposure to these environmental contami-
nants to response inhibition and executive 
control of behavior using ERPs recorded 
during a visual go/no-go task in a sample of 
school-age Inuit children participating to 
a birth-cohort study. Go/no-go tasks typi-
cally require a participant to press a button in 
response to a given set of stimuli (“go” condi-
tion) and to inhibit that action (not to press 
the same button) in response to a different set 
of stimuli (“no-go” condition). 
The go/no-go task employed in this study 
was developed for functional magnetic reso-
nance imaging by Casey et al. (1997), who 
reported increased prefrontal cortex activ-
ity during response inhibition. The task was 
adapted for ERPs by Davis et al. (2003), 
who examined two late-latency components 
in relation to response inhibition, the N2 
and the P3. The N2 is maximal > 300 msec 
post  stimulus over frontal electrode locations 
and has been attributed to conflict detec-
tion or to the decision to withhold a motor 
response (Falkenstein 2006). The P3, maxi-
mal approxi  mately 500 msec post  stimulus 
at centro  parietal electrodes, shows enhanced 
activity for no-go stimuli and is thought to 
reflect the amount of resources needed for 
task processing and/or efficiently inhibiting a 
motor response (Davis et al. 2003).
Error monitoring is another aspect of the 
executive control that can be assessed using 
ERPs. ERPs recorded after erroneous responses 
show two successive components, “error-  related 
negativity” (ERN) and “error positivity” (Pe). 
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Ba c k g r o u n d: Lead (Pb) and polychlorinated biphenyls (PCBs) are neurotoxic contaminants that 
have been related to impairment in response inhibition. 
oBjectives: In this study we examined the neurophysiological correlates of the response inhibition 
deficits associated with these exposures, using event-related potentials (ERPs) in a sample of school-
age Inuit children from Arctic Québec exposed through their traditional diet. 
Me t h o d s : In a prospective longitudinal study, we assessed 196 children (mean age, 11.3 years) on 
a visual go/no-go response inhibition paradigm. Pb, PCB, and mercury (Hg) concentrations were 
analyzed in cord and current blood samples. Hierarchical multiple regression analyses were con-
ducted to examine the associations of contaminant levels to go/no-go performance (mean reaction 
time, percent correct go, percent correct no-go) and five ERPs [N2, P3, error-related negativity, 
error positivity (Pe), and correct response positivity (Pc)] after control for confounding variables. 
re s u l t s: Current blood Pb concentrations were associated with higher rates of false alarms and 
with decreased P3 amplitudes to go and no-go trials. Current plasma PCB-153 concentrations 
were associated with slower reaction times and with reduced amplitudes of the Pe and Pc response-
related potentials. Hg concentrations were not related to any outcome on this task but showed sig-
nificant interactions with other contaminants on certain outcomes. 
co n c l u s i o n s: These results suggest that Pb exposure during childhood impairs the child’s abil-
ity to allocate the cognitive resources needed to correctly inhibit a prepotent response, resulting in 
increased impulsivity. By contrast, postnatal PCB exposure appears to affect processes associated 
with error monitoring, an aspect of behavioral regulation required to adequately adapt to the chang-
ing demands of the environment, which results in reduced task efficiency.
key w o r d s : event-related potentials, error monitoring, executive function, lead, methylmercury, 
neurotoxicity, polychlorinated biphenyls, response inhibition. Environ Health Perspect 120:608–615 
(2012).  http://dx.doi.org/10.1289/ehp.1103828 [Online 5 December 2011]Pb, PCB, and MeHg effects on an ERP go/no-go task
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The ERN is maximal over fronto  central elec-
trodes approximately 80 msec after an incor-
rect response and is thought to reflect the 
dynamics of response selection and conflict 
(Hughes and Yeung 2011). The Pe peaks 
200–400 msec after an incorrect response and 
is more centrally distributed; it is thought to 
reflect the conscious recognition, or motiva-
tional significance, of an error (Hughes and 
Yeung 2011; Overbeek et al. 2005). A few 
reports mention a similar component elic-
ited by correct responses: the “correct response 
positivity” (Pc) (Burgio-Murphy et al. 2007; 
Laurens et al. 2010).
We hypothesized that postnatal Pb and 
prenatal PCB exposures would both be asso-
ciated with increased impulsivity as reflected 
by behavioral performance in the go/no-go 
task and that these effects would be accompa-
nied by alterations in five ERP components: 
N2, P3, ERN, Pe, and Pc. Because this is, to 
our knowledge, the first study to use ERPs to 
assess the effects of Pb and PCBs on response 
inhibition, no hypothesis was made concern-
ing which components would be affected by 
each contaminant. Because response inhibition 
was not consistently associated with MeHg 
exposure in previous studies with children 
(e.g., Debes et al. 2006; Stewart et al. 2005; cf. 
Stewart et al. 2006), no hypothesis was put for-
ward concerning MeHg effects in this study.
Materials and Methods
Participants. The study participants were 
212 school-age Inuit children from Nunavik. 
The Nunavik region is located north of the 
55th parallel, about 1,500 km from Montreal. 
These children were originally recruited in the 
Cord Blood Monitoring Program (CBMP; 
1993–1998), which was designed to docu-
ment the levels of environmental contami-
nants and nutrients in newborns in Arctic 
Québec (Dallaire et al. 2001), except for one 
child who was recruited for the Environmental 
Contaminants and Child Development Study 
(1996–2000; Jacobson et al. 2008; Muckle 
et al. 2001), which was initiated during the 
latter part of the CBMP. Mothers were con-
tacted by telephone, provided with informa-
tion about the study protocol, and invited to 
participate with their children.
Assessments were conducted between 
September 2005 and April 2007 in the 
three largest Nunavik villages. Participants 
who resided in other communities were 
transported by plane to one of the larger vil-
lages for testing. A maternal interview was 
conducted to document information on 
demographic background, smoking, alcohol 
and drug use during pregnancy, and other 
maternal characteristics. The following inclu-
sion criteria were used: age between 9.0 and 
13.0 years, birth weight ≥ 2,500 g, gestation 
duration ≥ 35 weeks, no known neurological 
or clinically significant developmental disor-
der, and no medication for attention prob-
lems. Of the 212 participating children, 
2 with a history of epilepsy, 2 with a history 
of head trauma associated with loss of con-
sciousness and/or requiring hospitalization, 
1 with multiple sclerosis, and 1 with a history 
of meningitis were excluded after data collec-
tion. Written informed consent was obtained 
from a parent of each participant; oral assent 
was obtained from each child. The research 
was approved by the Laval University and 
Wayne State University ethics committees 
and was performed in accordance with ethical 
standards of the 1983 Helsinki Declaration.
Go/no-go protocol. Each participant was 
seated 57 cm from a 43-cm flat-panel monitor 
on which letters were displayed centrally within 
a 7 × 7-cm space. The child held a button box 
in his or her hand and was instructed to press 
the button as quickly and accurately as possible 
with the index finger for all individually pre-
sented letters (the “go” trials) except the target 
“X” (the “no-go” trials). The stimuli were pre-
sented for 500 msec, with random interstimu-
lus intervals ranging from 1,200 to 1,400 msec. 
The first block consisted of 40 go trials and 
served to prime go responses within the second 
block of trials. This second block consisted of 
126 go trials (70%) randomly intermixed with 
54 no-go trials (30%). Correct and incorrect 
responses were tabulated. Mean reaction time 
(RT; time between stimulus onset and button 
press) and response accuracy (percent correct) 
for go and no-go trials during the second block 
of trials were computed. Data from the initial 
block of 40 go trials were not analyzed (for a 
more detailed description of this protocol, see 
Burden et al. 2011).
Electroencephalogram recording and 
analyses. The electroencephalogram (EEG) 
was recorded with 30 Ag-AgCl electrodes 
placed according to the international 10–20 
system (Jasper 1958) referenced online 
to the vertex (Cz) electrode, with forehead 
ground. The electro-oculogram (EOG) was 
recorded from bipolar miniature electrodes 
placed vertically above and below the right 
eye. Impedance was kept < 10 kΩ. EOG and 
EEG gain were amplified with gains of 5,000 
and 50,000, respectively. The bandpass filter 
was 0.1–30 Hz, and a 60-Hz notch filter was 
engaged. The digitization rate was 200 Hz.
ERPs were derived and analyzed using 
Brain Vision Analyzer software (version 2.0; 
Brain Products, Munich, Germany). EEG 
channels were re-referenced offline to linked 
earlobes. EOG correction (Gratton et al. 
1983), artifact rejection (± 100 μV), and base-
line correction (100 msec) were applied. All 
responses occurring 200–1,600 msec after 
stimulus onset were considered valid. ERPs 
were averaged for correct go, correct no-go, 
and incorrect no-go responses separately. The 
“stimulus-locked” components, which are 
measured in relation to when the stimulus 
first appeared on the screen, were segmented 
100 msec before and 1,000 msec after stimu-
lus onset; the “response-locked” components, 
which are measured in relation to when the 
child pressed the button, were segmented 
300 msec before and 500 msec after but-
ton press. Peak amplitude (microvolts) and 
latency to peak (milliseconds) of the stimulus-
locked N2 (250–500 msec) component were 
identified using automatic detection. Mean 
amplitude values were computed for the stim-
ulus-locked P3 (400–700) and the response-
locked ERN (incorrect no-go, 0–125 msec), 
Pe (incorrect no-go, 100–500 msec), and Pc 
(correct go, 100–300 msec) components. 
The electrode site at which each ERP com-
ponent reached its maximal amplitude was 
used in analyses. Participants were retained in 
the analyses if their behavioral performance 
exceeded chance level on the task and if they 
had a sufficient number of acceptable trials in 
their ERP average (≥ 12 correct no-go trials for 
the stimulus-locked ERPs and ≥ 8 incorrect 
no-go trials for the response-locked ERPs).
Biological samples. Umbilical cord and 
child blood samples were analyzed for con-
centrations of Pb, PCBs, mercury (Hg), and 
polyunsaturated fatty acids (for a detailed 
description of the analytical procedures, see 
Boucher et al. 2011). Cord blood Pb levels 
were determined by graphite furnace atomic 
absorption with Zeeman background correc-
tion. Selected PCB congeners were measured 
in purified cord plasma extracts using high-
resolution gas chromatography with electron 
capture detection, and in purified child plasma 
extracts by high-resolution gas chromatog-
raphy/mass spectrometry. PCB congener 
153, expressed on a lipid basis, was used as 
an indicator of total PCB exposure because 
it is highly correlated with other PCB con-
geners and is considered an adequate marker 
of exposure to environmental PCB mixtures 
in the Arctic (Ayotte et al. 2003). Total Hg 
concentrations were determined in cord blood 
using cold-vapor atomic absorption spectrom-
etry. Total Pb and Hg concentrations in child 
blood samples were determined by inductively 
coupled plasma-mass spectrometry. The limits 
of detection (LODs) for cord sample analyses 
were 0.2 μg/dL for Pb and Hg, and 0.02 μg/L 
for all PCB congeners in plasma. LODs for 
child blood sample analyses were 0.002 μg/dL 
for Pb, 0.1 μg/L for Hg, and < 0.05 μg/L for 
most PCB congeners. A value equal to half 
the LOD was entered in the database when-
ever a substance was not detected. Omega-3 
fatty acid composition of plasma phospho-
lipids was analyzed using capillary gas-liquid 
chromatography with flame ionization detec-
tion. Concentrations of docosahexaenoic acid 
(DHA) were expressed as percentages of the Boucher et al.
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total area of all fatty acid peaks from C14:0 to 
C24:1 (percent weight).
Control variables. The following con-
trol variables were included: age and sex of 
child; whether or not the child was adopted; 
whether the child was transported by plane 
from a small, more remote village to a larger 
village for the assessment; time at ERP assess-
ment (morning vs. afternoon); maternal age at 
delivery; socioeconomic status (Hollingshead 
1975) of the primary caregiver; maternal non-
verbal reasoning abilities (Raven Progressive 
Matrices; Raven et al. 1992); breast-feeding 
duration (number of months); maternal 
tobacco smoking (yes/no), marijuana con-
sumption (yes/no), and binge drinking (at 
least one episode of ≥ 5 standard alcohol 
drinks; yes/no) during pregnancy; and DHA 
concentrations in cord and child plasma sam-
ples. In addition, in the analysis of each con-
taminant, the other contaminants were also 
treated as control variables.
Statistical analyses. Normality of distri-
bution was inspected visually for each vari-
able and checked for skewness (normality 
range, –3.0 to 3.0). Log transformations were 
performed on cord and current blood Pb, 
PCB-153, and Hg concentrations, breast-
feeding duration, and maternal tobacco con-
sumption during pregnancy because these 
variables followed log-normal distributions. 
Extreme values (> 3 SDs from the mean) for 
normally distributed independent and con-
founding variables were recoded to one point 
greater than the highest observed non  outlying 
value (Winer 1971).
The relation of each behavioral and ERP 
outcome to Pb, PCB-153, and Hg concentra-
tions in cord and current blood samples was 
examined in a series of hierarchical multiple 
regression analyses. Each of the control vari-
ables related at p < 0.20 to the outcome meas-
ure in question was entered hierarchically into 
a regression analysis, in which the contaminant 
being examined had been entered at the first 
step. The control variables were then entered 
individually using a forward selection 
approach (Greenland and Rothman 1998) 
with order of entry determined by the strength 
of the correlation of the control variable to the 
end point in question. Control variables were 
retained when their entry in the model altered 
the standardized regression coefficient for the 
contaminant variable by ≥ 10%. To explore 
possible interaction effects, all regression analy-
ses were rerun to add the interaction terms: 
first for cord Pb by cord Hg, then for cord Pb 
by cord PCB, and then for cord Hg by cord 
PCB. Similar analyses with interaction terms 
for the three childhood contaminant measures 
were also run. Because such interaction terms 
often lack the power to detect interactions, the 
regression analyses for cord Pb were also rerun 
separately for high and low cord Hg expo-
sure (split at the median) and then for cord 
PCB split at the median; the cord Hg regres-
sions were rerun split by cord Pb and then by 
cord PCB; and the cord PCB regressions were 
rerun and split by cord Pb and then by cord 
Hg. Similar stratified regressions were also run 
for the child contaminant measures.
Results
Descriptive statistics. A total of 196 participants 
were included in the final analyses. Reasons 
for exclusion were technical problems during 
recording (n = 4), too much noise in the EEG 
signal to produce a reliable ERP waveform 
(n = 3), and random responding on the task 
(n = 3). Compared with the retained partici-
pants, these 10 excluded participants had higher 
cord PCB-153 concentrations [t(199) = 2.57, 
p = 0.01] and tended to have higher current 
PCB-153 [t(200) = 1.83, p = 0.07] and Pb 
[t(201) = 1.84, p = 0.07] concentrations but did 
not differ on any of the other exposure or con-
trol variables (all p-values > 0.10). When the 
data from the children with too much noise in 
the EEG signal were included in the behavioral 
analyses and those with random responding 
were included, the results remained essentially 
unchanged. An additional three children were 
excluded from analyses involving stimulus-
locked components because of an insufficient 
number of trials in their ERP averaged wave-
form, and 30 were excluded from analyses 
involving response-locked components for the 
same reason. Those 33 participants excluded 
from either ERP analysis had higher PCB-153 
[t(189) = 3.16; p = 0.002] and Hg [t(191) = 2.10; 
p = 0.04] concentrations in cord blood and 
higher blood Hg concentrations at testing 
[t(191) = –2.42; p = 0.02].
Descriptive statistics of the final study 
sample are summarized in Table 1. Pb   levels 
at time of testing are similar to those reported 
in other epidemiological studies of low-level 
postnatal Pb exposure at school age (e.g., 
Table 1. Descriptive statistics for the study sample (n = 196).
Variables n Mean ± SD Median Range  Percent
Child age at assessment (years) 196 11.3 ± 0.6 11.4 9.8–12.9
Child sex (% girls) 196 55.1
Adoption status (% adopted) 196 15.8
Transportation by plane (% yes) 196 45.4
Time at ERP assessment (% morning) 196 53.1
Maternal characteristics
Age at delivery (years) 196 23.9 ± 5.8 22.0 15–42
Marital status (% single) 195 25.1
Education (years) 196 8.3 ± 2.6 8.5 0–16
Hollingshead score 196 28.9 ± 12.4 28.5 8.0–66.0
Raven score 196 35.1 ± 10.1 37.0 4–56
Breast-feeding durationa (months) 190 16.0 ± 17.5 11.5 0.1–108.0 68.4
Maternal use or consumption during pregnancy
Cigarettes (% yes) 189 82.0
Marijuana (% yes) 160 21.3
Binge drinking (≥ 5 standard drinks of alcohol 
per occasion; % yes)
160 31.3
Contaminants and other biological samples
Cord blood Pb (μg/dL) 193 4.8 ± 3.4 3.7 0.8–20.9
Current blood Pb (μg/dL) 193 2.6 ± 2.2 2.0 0.4–12.8
Cord plasma PCB-153 (μg/kg fat) 191 117.7 ± 90.9 93.3 9.7–653.6
Current plasma PCB-153 (μg/kg fat) 192 72.0 ± 70.7 45.7 3.5–431.4
Cord blood Hg (μg/L) 193 21.2 ± 17.6 16.6 1.0–99.3
Current blood Hg (μg/L) 193 4.6 ± 5.1 2.8 0.1–34.1
Cord plasma DHA (% phospholipids) 189 3.7 ± 1.3 3.5 1.1–7.7
Current plasma DHA (% phospholipids) 191 2.4 ± 1.0 2.2 0.1–5.5
Go/no-go behavioral performance
Mean RT, correct go trials (msec) 196 479.2 ± 75.8 472.0 322.0–720.0
Mean RT, incorrect no-go trials (msec) 196 419.5 ± 87.2 403.0 271.0–718.0
Correct go trials (%) 196 90.1 ± 9.7 93.2 52–100
Correct no-go trials (%) 196 64.0 ± 14.9 66.7 22–94
aFor women who breast-fed only.
Table 2. Intercorrelations among contaminants (Pearson correlation coefficients, r).
Pb PCB-153 Hg
Chemical Sample Cord Current Cord Current Cord Current
Pb Cord 1.00 0.17** 0.28* 0.29* 0.32* 0.18**
Current 1.00 0.04 0.25* 0.12 0.23*
PCB-153 Cord 1.00 0.45* 0.42* 0.25*
Current 1.00 0.41* 0.55*
Hg Cord 1.00 0.46*
Current 1.00
*p < 0.01. **p < 0.05. Pb, PCB, and MeHg effects on an ERP go/no-go task
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Surkan et al. 2007), although the levels meas-
ured at 11 years of age in this study are about 
half those seen at 5 years in a subsample of 
these participants (Boucher et al. 2009b). Five 
children had blood Pb concentrations above 
the 10-μg/dL threshold used by U.S. and 
Canadian public health agencies for evaluat-
ing risk of Pb neurotoxicity and were there-
fore referred to the appropriate public health 
authorities. Boys had higher blood Pb concen-
trations at time of testing than did girls (3.4 vs. 
2.0 μg/dL, p < 0.001), which probably reflects 
their greater involvement in hunting-related 
activities. Cord PCB concentrations are about 
three times higher than in southern Québec 
(Ayotte et al. 2003) and similar to those in the 
Dutch PCB study (Longnecker et al. 2003). 
Cord Hg concentrations are about 20 times 
higher than in southern Québec (Muckle et al. 
2001) and similar to those reported in children 
from the Faroe Islands (Debes et al. 2006).
Associations among the concentrations 
of contaminants measured at birth and at 
time of testing are presented in Table 2. Pb, 
PCB-153, and Hg are moderately associated 
with each other, presumably because these 
substances are found at relatively high con-
centrations in traditional Inuit food and fami-
lies vary in the degree to which they consume 
traditional food.
Behavioral performance. Values for mean 
RT and rates of correct responses on the go 
and no-go trials are presented in Table 1. 
Repeated-measures analysis of variance 
(ANOVA) showed that, as expected, partici-
pants are more accurate on go than on no-go 
trials [F(1,195) = 655.4, p < 0.001]. Faster mean 
RT for go trials is associated with more accu-
rate detection of go (r = –0.31, p < 0.001) and 
no-go (r = –0.19, p < 0.001) trials. Rates of 
correct responses for go trials are positively 
associated with rates of correct responses for 
no-go trials (r = 0.39, p < 0.001).
Results from the regression analyses testing 
for associations between contaminant concen-
trations and behavioral go/no-go performance 
are presented in Table 3. After control for 
confounding factors, higher Pb concentra-
tions in cord blood are associated with fewer 
correct responses for both go and no-go trials. 
Higher blood Pb concentrations at time of 
testing are associated with an increased num-
ber of false alarms in no-go trials, suggesting 
difficulty in inhibiting a prepotent response. 
This association falls just short of statistical 
significance when participants with blood 
Pb concentrations ≥ 5 μg/dL are excluded 
(n = 175; r = –0.18, p = 0.02; standard-
ized β = –0.14, p = 0.078). Current plasma 
PCB-153 concentrations are associated with 
slower responses to go trials. PCB-153 con-
centrations in cord plasma and Hg concentra-
tions in cord and child blood samples were not 
associated with any of the behavioral measures 
after statistical control for confounding vari-
ables (all p-values > 0.10). Figure 1 illustrates 
mean performance per quartile of exposure 
on each outcome significantly associated with 
a contaminant. Postnatal Pb and PCB-153 
effects seem linear, whereas the adverse effects 
of prenatal Pb are mainly observed in the 
highest-exposed children.
Testing for interactions revealed inter-
action effects for cord Pb with both cord 
PCB and cord Hg for three behavioral mea-
sures: incorrect no-go RT (standardized β: 
Pb × PCB = 0.14, p = 0.05; Pb × Hg = 0.12, 
p = 0.10 percent correct go (standardized β: 
Pb × PCB = –0.17, p = 0.04; Pb × Hg = –0.15, 
p = 0.07), and percent correct no-go trials 
(standardized β: Pb × PCB = –0.11, p = 0.12; 
Pb × Hg = –0.18, p = 0.01). Although not all 
these interactions reached conventional lev-
els of statistical significance, the stratification 
analyses showed that the effects of cord Pb 
were seen primarily in the children with higher 
prenatal PCB and/or Hg exposures, indicating 
that the effects of prenatal Pb exposure were 
intensified by heavier PCB and Hg exposures.
Stimulus-locked ERPs.  In repeated-
  measures ANOVAs with condition (go 
vs. no-go) as a within-subject variable, P3 
amplitude at parietal electrode (Pz) was sig-
nificantly larger for no-go than for go trials 
[10.1 vs. 5.0 μV; F(1,192) = 119.7, p < 0.001], 
reflecting the additional resources needed to 
inhibit a prepotent response. No condition 
effect was found for N2 [frontal electrode 
(Fz)] latency (go: 375.9 msec; no-go: 370.7 
msec) and amplitude (go: –7.4 μV; no-go: 
–7.8 μV; p-values > 0.20). Slower N2 latency 
was associated with slower mean hit RT (go 
N2: r = 0.35, p < 0.001; no-go N2: r = 0.30, 
p < 0.001) and with lower percent correct 
go trials (go N2: r = –0.23, p = 0.001; no-go 
N2: r = –0.30, p < 0.001). Greater P3 ampli-
tude was significantly associated with greater 
percent correct go trials (go P3: r = 0.21, 
Table 3. Associations between contaminants and behavioral performance in the go/no-go task (n = 196).
Pb PCB-153 Hg
Cord blood Current blood Cord plasma Current plasma Cord blood Current blood
Behavioral outcome r β r β r β r β r β r β
Mean RT, correct go trials 0.06 –0.05a,b,c,d,e,f –0.01 0.03a,b,c,d,f 0.15** 0.04b,c,e,f 0.17** 0.18**b,c,e,f 0.13# 0.04a,b,c,d,f 0.15** 0.10a,b,c,d,f
Mean RT, incorrect no-go trials 0.14# 0.10a,b,d,g,h 0.01 0.03a,b,d,g 0.16** 0.07b,g,h,i 0.17** 0.06b,g,i 0.10 0.03a,b,d,h,i,j 0.20* 0.11a,b,d,h
Percent correct go –0.12# –0.21**h,k,l –0.11 –0.12k,l –0.01 0.03h,i,k,l –0.06 –0.01a,h,i,k,l –0.03 0.06a,h,k,i,l –0.11 –0.02a,h,i,l
Percent correct no-go –0.16** –0.17**b,d –0.20* –0.16**b,m 0.05 0.06b,i,k,m,n,o –0.12 –0.06b,i,k,n,o –0.06 0.07b,d,i,m,n –0.07 –0.03b,i,k,m,o
Values are Pearson correlation (r) and standardized regression (β) coefficients from multiple regression analyses. Superscripts (a–o) indicate control variables included in the final 
model for each of the regression analyses. 
aChild age. bChild sex. cAdoption status. dChild PCB-153. eCord Hg. fChild DHA. gChild Hg. hCord DHA. iCord Pb. jCord PCB-153. kTime at assessment. lMaternal marijuana during preg-
nancy. mBreast-feeding duration. nTransported from a remote village. oChild Pb. *p < 0.01. **p < 0.05. #p < 0.10.
Figure 1. Mean ± SD behavioral performance in the go/no-go task according to quartiles of exposure: (A,B) cord blood Pb, (C) 11-year blood Pb, and (D) 11-year 
plasma PCB-153. Outcome measures are adjusted for the potential confounders listed in Table 3.
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p = 0.003; no-go P3: r = 0.29, p < 0.001), 
and P3 amplitude to go trials tended to be 
related to greater percent correct no-go trials 
(r = 0.14, p = 0.051).
Results from the regression analyses testing 
for associations between contaminants and 
the stimulus-locked ERP parameters are pre-
sented in Table 4. Higher current blood Pb 
concentrations are associated with reduced 
P3 amplitude to go and no-go trials. When 
participants with current blood Pb concen-
trations ≥ 5 μg/dL are excluded, this effect 
is still significant for no-go P3 amplitude 
(r = –0.24, p = 0.001; standardized β = –0.21, 
p = 0.007) but falls short of significance for go 
P3 amplitude (r = –0.16, p = 0.04; standard-
ized β = –0.09, p = 0.22). The effect of current 
blood Pb concentrations on P3 amplitude is 
clearly observable when contrasting the ERP 
averages of the bottom and top quartiles of 
the distributions for current blood Pb con-
centration (adjusted mean ± SD no-go P3 
amplitude, 12.8 ± 7.0 μV vs. 7.8 ± 8.1 μV, 
Cohen’s d = –0.66; see Figure 2). The asso-
ciation between cord PCB-153 and go N2 
latency falls short of statistical significance 
after controlling for maternal age at delivery 
(p = 0.053), suggesting delayed N2 latency 
with increasing prenatal exposure. Analyses 
with Hg revealed an association between cur-
rent blood Hg concentrations and reduced P3 
amplitude in the go condition that fell short 
of statistical significance after controlling for 
confounders (p = 0.052). Cord blood Hg and 
current plasma PCB-153 concentrations levels 
were not significantly associated with any of 
the stimulus-locked ERPs.
Interaction terms revealed significant inter-
actions between current Pb and current Hg 
on P3 amplitude elicited in the go condition 
(standardized β = 0.15, p = 0.04) and between 
current Pb and current PCB-153 on P3 
amplitude elicited in both the go (standard-
ized β = 0.17, p = 0.02) and the no-go (stan-
dardized β = 0.13, p = 0.08) conditions. In all 
cases, the Pb effects were stronger in children 
with lower coexposures to the other chemi-
cals. There were also significant interactions 
between cord Hg and cord PCB-153 on 
no-go N2 latency (standardized β = 0.16, 
p = 0.05) and no-go P3 amplitude (standard-
ized β = –0.20, p = 0.02). Stratification analy-
ses revealed that higher cord Hg resulted in 
slower no-go N2 latency, and smaller no-go 
P3 amplitude in children with higher pre-
natal PCB exposure, but higher no-go N2 
amplitude only in children with lower pre  natal 
PCB exposure.
Response-locked ERPs. Repeated-measures 
ANOVAs with response type (correct go, 
incorrect no-go) as a within-subject variable 
revealed significant error-related effects on 
mean amplitude during the ERN [fronto-
central electrode (FCz): 0.3 vs. –4.0 μV; 
Table 4. Associations between contaminants and stimulus-locked ERP components recorded during the go/no-go task (n = 193).
Pb PCB-153 Hg
Cord blood Current blood Cord plasma Current plasma Cord blood Current blood
ERP parameter r β r β r β r β r β r β
N2 (Fz)
Go latency –0.01 0.08a,b 0.05 0.02b,c 0.09 0.15#a 0.05 0.08a,c 0.08 0.05a,b 0.01 0.02a,c
No-go latency –0.03 –0.01d,e,f,g,h 0.01 –0.01d,f,g,h 0.01 –0.11d,f,g,h 0.14# 0.01e,f,h 0.09 0.04d,e,f,g,i 0.16** 0.11d,f
Go amplitude 0.03 0.08j,k 0.02 0.02d,j,k –0.03 0.00d,j,k 0.01 0.07d,j 0.09 0.13#d,j 0.01 0.06d,j,k
No-go amplitude –0.00 0.02a,f,j,k,l,m 0.00 0.05j,k,l,m –0.05 –0.01a,f,j,l,m 0.04 0.01a,f,j,k,l,m 0.02 0.03a,f,j,k,l,m 0.04 0.02a,f,j,k,l,m
P3 (Pz)
Go amplitude –0.06 –0.05c,h,l –0.20* –0.16**h 0.03 0.08c,h,l,n,o –0.13# –0.01c,h,l,n,o –0.08 –0.02i,l,n,o –0.21* –0.15#n,o
No-go amplitude –0.06 –0.06a,g,l,p –0.26* –0.23*h 0.04 0.12a,l,o,p –0.13# –0.01a,l,o,p –0.14# –0.10a,g,l,o –0.18** –0.06a,g,i,l,o
Values are Pearson correlation (r) and standardized regression (β) coefficients from multiple regression analyses. Negative (–) associations with N2 amplitude indicate greater (more 
negative) amplitude. Superscripts (a–p) indicate control variables included in the final model for each of the regression analyses. 
aMaternal age. bCord PCB-153. cTime at assessment. dChild age. eAdoption status. fMaternal binge drinking during pregnancy. gBreast-feeding duration. hChild Hg. iChild PCB-153. 
jCord DHA. kMaternal Raven’s score. lMaternal smoking during pregnancy. mChild sex. nTransported from a remote village. oChild Pb. pCord Hg. *p < 0.01. **p < 0.05. #p < 0.10.
Figure 2. Grand average for stimulus-locked go/no-go ERPs at midline electrodes comparing participants 
from the first quartile of blood Pb concentrations at time of testing (range, 0.4–1.3 μg/dL; n = 47; thin lines) 
and those from the fourth quartile (range, 2.9–12.8 μg/dL; n = 48; thick lines) for go (solid lines) and no-go 
(dashed lines) trials. The N2 is the second negative component (~ 375 msec), which is more pronounced 
at the frontal lead (Fz). The P3 peaks around 500 msec and is larger at the parietal lead (Pz). Children with 
higher blood Pb concentrations show reduced activity during the P3 time window compared with children 
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F(1,166) = 81.6, p < 0.001], Pe [Cz: 1.7 vs. 8.2 
μV; F(1,166) = 127.1, p < 0.001], and Pc [FCz: 
4.4 vs. 6.7 μV; F(1,166) = 13.9, p < 0.001] 
latency intervals. Smaller ERN and Pe ampli-
tudes tended to be associated with slower 
mean hit RT (ERN: r = 0.15, p = 0.052; Pe: 
r = –0.14, p = 0.07), and amplitudes of all 
three error monitoring components were sig-
nificantly associated with higher percent cor-
rect go trials (ERN: r = –0.19, p = 0.02; Pe: 
r = 0.25, p = 0.001; Pc: r = 0.18, p = 0.02) 
and higher percent correct no-go trials (ERN: 
r = –0.23, p = 0.003; Pe: r = 0.25, p = 0.001; 
Pc: r = 0.16, p = 0.04).
Results from the regression analyses test-
ing for associations between contaminants 
and response-locked ERP parameters are pre-
sented in Table 5. After statistical control for 
confounders, higher plasma PCB-153 con-
centrations at time of testing are associated 
with reduced amplitude of the components 
Pe, elicited by false alarms, and Pc, elicited 
by correct hits. These effects are illustrated in 
Figure 3, which compares children from the 
bottom and top quartiles of current plasma 
PCB-153 concentrations (adjusted mean 
± SD Pc amplitude, 5.5 ± 4.0 μV vs. 2.8 ± 
4.8 μV, Cohen’s d = –0.61). Pb and Hg con-
centrations in cord and child blood samples 
were not associated with any of the response-
locked ERP measures in standard regression 
analyses (all p-values > 0.10).
The effects of current plasma PCBs on 
response-locked ERPs did not interact with 
the other contaminants (all p-values > 0.15).
Discussion
In this study we examined the association of 
developmental exposure to Pb, PCBs, and 
MeHg with response inhibition in 11-year-
old children using ERPs recorded during a 
visual go/no-go task. Blood Pb concentra-
tions at time of testing were associated with 
higher rates of false alarms during the task 
and with reduced amplitude of the P3 wave 
elicited by go and no-go stimuli, suggesting 
reduced allocation of cognitive resources for 
task processing. Surprisingly, the effects of 
current Pb on P3 amplitudes were stronger in 
children with lower current MeHg and PCB 
exposures, which suggests that coexposure to 
the other contaminants may make the adverse 
Pb effects on these end points more difficult 
to detect. By contrast, plasma PCB-153 con-
centrations at time of testing were associated 
with slower RTs to go trials and with reduced 
amplitude of the Pe/Pc components, which 
are believed to reflect post  response brain activ-
ity involved in error monitoring. Higher cord 
blood Pb concentrations were associated with 
poorer performance during the task (although 
not with any of ERP parameters), and the 
behavioral effects were markedly stronger in 
children with higher levels of prenatal expo-
sure to MeHg and to PCBs. Cord PCB-153 
levels were marginally associated with delayed 
latency of the N2 component in the go but 
not in the no-go condition.
We previously assessed the relation 
of postnatal Pb exposure to ERPs recorded 
during a simple auditory oddball detection 
paradigm and found no effect of Pb on the 
P3 component recorded during this task at 
school age (Boucher et al. 2009b). The finding 
of decreased P3 amplitude to go and no-go 
stimuli as a function of current blood Pb con-
centrations in the present analyses suggests 
Table 5. Associations between contaminants and response-locked ERP amplitudes recorded during the go/no-go task (n = 166).
Pb PCB-153 Hg
Cord blood Current blood Cord plasma Current plasma Cord blood Current blood
ERP parameter r β r β r β r β r β r β
ERN (FCz) 0.03 –0.02a,b,c,d 0.09 0.11a,d 0.07 –0.03a,c,d 0.06 0.02a,b,c,d 0.12 0.11a,c 0.10 0.07c
Pe (Cz) –0.11 –0.07a,e –0.11 –0.00a,e,f 0.07 0.11a,g,h –0.18** –0.16**i –0.09 0.05a,e,f,g –0.11 –0.03a,e,f
Pc (FCz) –0.19** –0.12e –0.10 –0.00a,b,e,j –0.08 –0.03a,b,f,g,j –0.23* –0.20**g –0.12 0.01a,e,g,j –0.10 0.01a,b,e,f,j
Values are Pearson correlation (r) and standardized regression (β) coefficients from multiple regression analyses. Negative (–) associations with ERN amplitude indicate greater (more 
negative) amplitude. Superscripts (a–j) indicate control variables included in the final model for each of the regression analyses. 
aChild sex. bAdoption status. cTransported from a remote village. dCord Hg. eChild PCB-153. fBreast-feeding duration. gCord Pb. hChild Hg. iChild Pb. jChild age. *p < 0.01. **p < 0.05.
Figure 3. Grand average for response-locked go/no-go ERPs at midline electrodes comparing participants 
from the first quartile of plasma PCB-153 concentrations at time of testing (range, 3.5–26.0 μg/g fat; n = 46; thin 
lines) to those from the fourth quartile (range, 96.6–431.4 μg/g fat; n = 42; thick lines). Incorrect no-go trials 
(false alarms; dashed lines) elicit an early wave of negative voltage (ERN) followed by a large positive wave 
(Pe) maximal at the vertex (Cz). Correct go responses (solid lines) generate a frontocentral wave of positive 
voltage in the 100–300 msec (Pc) latency interval. Children with higher plasma PCB-153 concentrations show 















–100 200 100 300 400
ms
0
1st plasma PCB-153 quartile
Go correct  No-go incorrect
4th plasma PCB-153 quartile
Go correct  No-go incorrect Boucher et al.
614  v o l u m e  120 | n u m b e r 4 | April 2012  •  Environmental Health Perspectives
that adverse effects of childhood Pb exposure 
are detected more readily when higher-order, 
executive processes (i.e., response inhibition) 
are elicited. This inference is also supported 
by the finding that the association of postnatal 
Pb with P3 amplitude was more marked in 
the no-go than in the go condition. Impulse 
control and inhibition have been shown to 
be specifically impaired in Pb-exposed ani-
mals (Brockel and Cory-Slechta 1998), and 
evidence is accumulating that these aspects 
of cognition are among the most sensi-
tive to Pb exposure in children. Higher rat-
ings of impulsive and inattentive behavior, 
impaired response inhibition, and increased 
risk of attention deficit hyperactivity disor-
der have been reported in samples of children 
with mean blood Pb concentrations as low as 
≤ 5 μg/dL (Froehlich et al. 2009; Nicolescu 
et al. 2010; Stewart et al. 2006; Surkan et al. 
2007). These effects suggest enhanced vulner-
ability of the prefrontal cortex to Pb neuro-
toxicity during childhood, a hypothesis that 
has been supported by imaging studies reveal-
ing specific structural (Cecil et al. 2008) and 
metabolic (Cecil et al. 2011; Meng et al. 2005) 
Pb-associated alterations in this region of the 
brain. The present study adds to this evidence 
by reporting an inverse relation between blood 
Pb levels (< 5 μg/dL) and amplitude of the 
no-go P3 ERP component, which is believed 
to be generated within the prefrontal cortex 
(Davis et al. 2003). These effects, observed at 
such low Pb levels, also strengthen the argu-
ments for revising the blood Pb concentra-
tions considered “acceptable” by public health 
agencies from 10 μg/dL (Centers for Disease 
Control and Prevention 1991; Health Canada 
1994) to a lower value. The mean blood Pb 
concentration in this study is similar to that 
reported for preschool children from the gen-
eral U.S. population during the mid-1990s 
(Jones et al. 2009), which adds to the grow-
ing body of evidence that a large proportion 
of children exposed at levels considered safe 
under current public health recommenda-
tions actually show subtle adverse effects from 
Pb neurotoxicity (e.g., Chiodo et al. 2004; 
Lanphear et al. 2000).
In this study, cord blood Pb concentra-
tions were associated with increased errors 
in both the go and no-go trials. This pattern 
of results may reflect an effect of prenatal Pb 
exposure on attention and cognitive function 
generally rather than the specific effect on 
response inhibition seen in relation to cur-
rent Pb only on the no-go trials. This may 
explain why no effect of prenatal Pb exposure 
was observed on the ERP measures. Adverse 
effects of prenatal Pb exposure on attention 
have been reported in previous assessments 
conducted on this same cohort of children 
(Boucher et al. 2009b; Plusquellec et al. 
2007). Although no adverse behavioral effects 
were seen in relation to prenatal PCB expo-
sure on this relatively simple task, the ERP 
data suggest impairment in processing that 
would be expected to affect performance in a 
more challenging task.
The delayed RTs and reduced Pe/Pc 
amplitudes seen in relation to postnatal PCB 
exposure in this study suggest that PCB expo-
sure alters the neural processes involved in 
error monitoring. Neural generators of the 
Pe have been localized, notably, in the rostral 
portion of the anterior cingulate cortex (ACC) 
(Herrmann et al. 2004; Van Veen and Carter 
2002). Lesions involving the rostral ACC 
have been associated with impairment in the 
regulation of cognitive control after response 
conflict, leading to poor context-dependent 
adjustments of behavior (Di Pellegrino et al. 
2007). Poorer behavioral regulation in rela-
tion to contextual information, such as pre-
vious errors, might account for the high 
sensitivity of delayed reinforcement paradigms 
and of tasks assessing planning and response 
inhibition to early PCB exposure (Jacobson 
and Jacobson 1996, 2003; Lilienthal et al. 
1990; Rice 1999; Stewart et al. 2005, 2006; 
Vreugdenhil et al. 2004).
Most previous birth cohort studies on PCB 
neurotoxicity have reported adverse effects of 
prenatal but not postnatal PCB exposure on 
cognition (e.g., Boucher et al. 2009a; Jacobson 
and Jacobson 1996; Jacobson et al. 1985). The 
effects associated with postnatal PCB expo-
sure in this study are likely explained by the 
typically longer period of breast-feeding in 
this Inuit sample and the substantial quanti-
ties of PCB-contaminated traditional Inuit 
food eaten by these children than that seen in 
U.S. and southern Canadian children. This 
extended breast-feeding likely has led to post-
natal transmission of much larger quantities of 
these contaminants than in other PCB cohort 
studies. Adverse neurobehavioral effects of 
postnatal PCB have been demonstrated in 
experimental studies with animals (e.g., Rice 
1999), supporting the plausibility of adverse 
effects from postnatal PCB exposure when the 
levels are sufficiently high.
Although cord and child Hg levels were 
correlated with some of the behavioral and 
ERP measures, virtually none of these asso-
ciations remained significant once other con-
taminants or covariates were included in the 
analysis. The synergistic effects between cord 
Hg and cord PCB seen on some neurobehav-
ioral end points by Grandjean et al. (2001) 
were not seen consistently in this study. 
Although the stratified analyses indicated 
effects of cord Hg on three ERP measures in 
the children with heavier prenatal PCB expo-
sures, the effect on a fourth ERP measure was 
stronger in children with lower prenatal PCB 
exposure. It has been suggested that statisti-
cal control for seafood nutrients, such as the 
polyunsaturated fatty acid DHA, may provide 
a better estimation of the effects of MeHg 
exposure (Budtz-Jørgensen et al. 2007). The 
absence of clear effects even after statistical 
control for DHA in the present study there-
fore provides additional support for the con-
clusion that response inhibition and error 
monitoring are not specific targets of MeHg 
neurotoxicity in children.
Conclusion
This study was designed to examine the neuro-
physiological correlates of response inhibi-
tion impairment associated with Pb and PCB 
exposures in children. The results suggest that 
childhood Pb exposure specifically impairs the 
allocation of the resources needed for correctly 
inhibiting a prepotent response, which results 
in increased impulsivity. By contrast, postnatal 
PCB exposure appears to affect the processes 
associated with error monitoring, an aspect of 
behavioral regulation required to adequately 
adapt to the changing demands of the envi-
ronment, which has been localized within the 
ACC. This effect results in reduced task effi-
ciency and may play a role in the PCB-related 
cognitive impairments reported in previous 
studies. The present data demonstrate the util-
ity of ERPs in advancing understanding of the 
mechanisms underlying the neurotoxicity of 
environmental contaminants.
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